A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Clinical trial NCT03114657 · TERMINATED
Trial details
- NCT number
- NCT03114657
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-29
- Primary completion
- 2019-06-11
- Enrollment
- 806
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.